Chicago, June 10 – – Iqvia Holdings Inc. announced that its subsidiary Iqvia Inc. sold €711 million of 2 7/8% senior notes (Ba3/BB) due June 15, 2028, according to a news release on Wednesday.
The proceeds from the Rule 144A and Regulation S notes will be used to redeem all of the 3˝% notes due 2024 and to repay a portion of the existing borrowings under the issuer’s revolving credit facility.
The provider of health information technologies and clinical research is based in Durham, N.C.
| Issuer: | Iqvia Inc.
|
| Issue: | Senior notes
|
| Amount: | €711 million
|
| Maturity: | June 15, 2028
|
| Coupon: | 2 7/8%
|
| Pricing date: | June 10
|
| Settlement date: | June 24
|
| Ratings: | Moody’s: Ba3
|
| S&P: BB
|
| Distribution: | Rule 144A and Regulation S
|
|
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.
